ArticleLeukemia2020

A novel BCMA PBD-ADC with ATM/ATR/WEE1 inhibitors or bortezomib induce synergistic lethality in multiple myeloma.

Lijie Xing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.